Veregen 10%
Veregen 10% is a medicine authorised by Swissmedic under authorisation number 61895. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Herbal medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 March 2012 and the authorisation is valid without a time limit. ATC code D06BB12 places the medicine in the group Antibiotics and chemotherapeutics for dermatological use.
| Authorisation number | 61895 |
|---|---|
| Name | Veregen 10% |
| Full name | Veregen 10%, Salbe |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Herbal medicines |
| Dispensing category | B · Prescription only |
| ATC code | D06BB12 |
| First authorisation | 27 March 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Veregen 10%, Salbe | B | 27 March 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 15 | g | D06BB12 | 10.99.0. | B |
| 2 | 30 | g | D06BB12 | 10.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Veregen 10% authorised in Switzerland?
Yes. Veregen 10% is authorised by Swissmedic under authorisation number 61895, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Veregen 10% have?
Veregen 10% is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Veregen 10%?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.